Related Experiment Video

Updated: Jun 6, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma

Nicolaus Friedrichs1, Marcel Trautmann, Elmar Endl

  • 1Department of Pathology, University of Bonn Medical Center, Bonn, Germany.

International Journal of Cancer
|December 4, 2010
PubMed

Insights

The phosphoinositide 3-kinase (PI3K)/AKT pathway is crucial for synovial sarcoma growth. Inhibiting this pathway reduces tumor cell proliferation and enhances apoptosis, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Synovial sarcomas are rare soft tissue tumors.
  • These tumors often express growth factor receptors activating intracellular kinase cascades.
  • The role of PI3K/AKT signaling in synovial sarcoma biology and treatment is not fully understood.

Purpose of the Study:

  • To investigate the functional role of the PI3K/AKT signaling pathway in synovial sarcoma.
  • To assess the therapeutic potential of targeting PI3K/AKT signaling in synovial sarcoma.

Main Methods:

  • Immunohistochemical analysis of PI3K/AKT pathway markers (p-AKT, p-GSK-3β, p-mTOR) and cell cycle regulators (Cyclin D1, p27KIP1) in 36 synovial sarcomas.
  • Screening for PIK3CA gene mutations.
  • In vitro studies using four synovial sarcoma cell lines treated with PI3K inhibitor LY294002 to assess effects on signaling, proliferation, and apoptosis.
  • Combination treatment of cell lines with LY294002 and cytotoxic drugs.

Main Results:

  • Most tumors exhibited activated PI3K/AKT signaling (high p-AKT, p-GSK-3β, p-mTOR) with differential expression of Cyclin D1 and p27KIP1.
  • PIK3CA mutations were not found.
  • In vitro, PI3K inhibition decreased cell growth, reduced pathway signaling, enhanced apoptosis, and decreased proliferation.
  • PI3K inhibition led to reduced Cyclin D1 and increased p27KIP1 levels.
  • Combined treatment with LY294002 and cytotoxic drugs showed additive effects.

Conclusions:

  • The PI3K/AKT signaling pathway is essential for synovial sarcoma growth control.
  • Targeting PI3K signaling represents a promising strategy for multimodal therapeutic approaches in synovial sarcoma.
  • PI3K inhibition effectively reduces tumor cell proliferation and induces apoptosis in synovial sarcoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...